T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRK
376
DELISTED
WestRock Company
WRK
| $206M | 0.03% |
5,859,186
-63,877
| -1% | -$2.23M |
|
377
CNA Financial
CNA
$13.7B
| $206M | 0.03% |
4,870,117
-180,971
| -4% | -$7.42M |
|
378
Quest Diagnostics
DGX
$26.1B
| $201M | 0.03% |
1,287,496
-405,451
| -24% | -$58.3M |
|
379
Insmed
INSM
$27.9B
| $199M | 0.03% |
9,977,911
+429,664
| +4% | +$8.3M |
|
380
Southern Copper
SCCO
$159B
| $194M | 0.03% |
3,512,233
-1,209,358
| -26% | -$61M |
|
381
WillScot Mobile Mini Holdings
WSC
$4.07B
| $194M | 0.03% |
4,292,869
+640,539
| +18% | +$28.7M |
|
382
Bunge Global
BG
$21.7B
| $194M | 0.03% |
1,943,255
-299,004
| -13% | -$28.7M |
|
383
Prothena Corp
PRTA
$468M
| $193M | 0.03% |
3,205,903
+223,962
| +8% | +$13.1M |
|
384
CubeSmart
CUBE
$9.4B
| $193M | 0.03% |
4,788,885
-548,336
| -10% | -$22.1M |
|
|
OLK
385
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $193M | 0.03% |
7,594,025
+31,332
| +0.4% | +$630K |
|
386
Nucor
NUE
$62B
| $191M | 0.03% |
1,451,906
-4,878
| -0.3% | -$663K |
|
387
SLB Ltd
SLB
$77.2B
| $191M | 0.03% |
3,577,741
+1,743,853
| +95% | +$86.8M |
|
388
Ultragenyx Pharmaceutical
RARE
$2.62B
| $190M | 0.03% |
4,096,388
-660,568
| -14% | -$26M |
|
|
BDXB
389
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| – | – |
0
| – | – |
|
|
BPMC
390
DELISTED
Blueprint Medicines
BPMC
| $188M | 0.03% |
4,299,290
+267,479
| +7% | +$12.8M |
|
|
PARA
391
DELISTED
Paramount Global Class B
PARA
| $183M | 0.03% |
10,827,484
+79,641
| +0.7% | +$1.47M |
|
392
Vodafone
VOD
$37.4B
| $183M | 0.03% |
18,051,268
-2,611,161
| -13% | -$29.3M |
|
393
Tractor Supply
TSCO
$18.6B
| $181M | 0.03% |
4,026,190
-108,630
| -3% | -$4.61M |
|
394
Mohawk Industries
MHK
$9.45B
| $178M | 0.03% |
1,744,679
+4,710
| +0.3% | +$462K |
|
395
Workday
WDAY
$48.9B
| $177M | 0.03% |
1,059,282
-154,469
| -13% | -$24.1M |
|
396
ResMed
RMD
$32.8B
| $177M | 0.03% |
849,576
+92,261
| +12% | +$20.3M |
|
397
Enphase Energy
ENPH
$5.36B
| $177M | 0.03% |
667,303
+309,665
| +87% | +$90.1M |
|
398
AerCap
AER
$23.4B
| $174M | 0.03% |
2,985,228
-72,614
| -2% | -$4.01M |
|
399
NiSource
NI
$20.2B
| $173M | 0.03% |
6,295,878
-9,155,638
| -59% | -$241M |
|
400
HDFC Bank
HDB
$119B
| $173M | 0.03% |
5,043,628
+907,810
| +22% | +$29.5M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.